Assyro AI

Orange Book product · Brand (NDA)

TYKERB

LAPATINIB DITOSYLATE

Brand (NDA)NDA 022059TE ABRX NOVARTIS

At a glance

Mar 13, 2007

Approved

Brand (NDA)

Application

AB

TE code

1

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Mar 13, 2007

    19 yr 7 mo ago

  2. Today

  3. Patent 8821927 expires

    Listed drug substance patent expiration.

    Sep 18, 2029

    in 3 yr 4 mo

Pharmaceutical detail

Active ingredient

LAPATINIB DITOSYLATE

Strength

EQ 250MG BASE

Dosage form

TABLET

Route

ORAL

TE code

AB

Application

NDA 022059

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Listed patents (1)

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
PatentExpiresInType
8821927Sep 18, 2029in 3 yr 4 mo
SubstanceProduct
Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.